360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment. Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas Expertise in virology, immunology and analytical chemistry. World-class facilities with BSL-2, BSL-3 & quarantine laboratories > Quality management systems to ensure that “every sample counts”

Agilex Biolabs offers a range of toxicology services to support preclinical through to early/late-phase clinical programs through TetraQ, an established GLP facility located in Brisbane, Australia. These services include exploratory toxicology and pharmacokinetics studies, and GLP toxicology services. We have expertise with all types of molecules, laboratory species, routes of administration, and non-clinical studies.

Bellaseno is a clinical-stage medical device company focusing on regenerative implants produced by additive manufacturing across multiple structural tissue reconstruction applications. BellaSeno develops fully resorbable implants that support the growth of natural tissue and get absorbed over time. BellaSeno’s innovative technology platform provide broad-spectrum design & manufacturing possibilities to provide a step change in multiple healthcare segments.

A privately held consulting business helping researchers, industry and elected officials address strategic issues in life sciences innovation.

Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK.

Brisbane Economic Development Agency (BEDA) drives the sustainable economic growth of the city.  As Brisbane’s champion, BEDA works closely with government and private sector organisations to enhance and promote the city’s reputation globally and drive demand for Brisbane.

CROW Clinical is a full service and tailorable Clinical Research Organization servicing Australia and New Zealand. We are the only CRO that offers a dedicated team of Field Clinical Engineers. We specialize in high tech medical device start ups and CROW Clinical is the experts for Med Tech and Biotech clinical trials. We pride ourselves on tailoring a specific service, so you only pay for exactly what you need. We are a premier Clinical Research Organization without the huge price tag.

Canaria Technologies is a market leader in Predictive Biometrics Systems, providing non-invasive wearable devices powered by proprietary biometric algorithms to predict and prevent Cognitive Fatigue and Heat Stress. We are working with the world's biggest companies across the global resources sector, allowing technology and safety to come together in life-threatening situations.

Carpe Vitae Pharmaceuticals specializes in developing drugs that target novel DNA damage response mechanisms. Their lead program, DRpin (CPV003), utilizes a platform technology for rational drug design to target transcription factors in cancer treatment. The first drug in this program, DRpin-Myc, focuses on Myc, a well-known cancer driver present in 70% of human cancers. Preclinical studies have shown promising results, and it is expected to enter Phase 1 trials by late 2024. Carpe Vitae is also exploring other drugs from the DRpin platform that target different transcription factors, with preclinical testing underway.

Clinials is an AI-Driven clinical trial participant recruitment platform. We help researchers and pharmaceutical companies find eligible and engaged participants for their trials. Born in Brisbane, Australia – the world’s test bed for clinical trials, Clinials has global experience with clinical trial recruitment. .

Coral Sea Clinical Research Institute is a clinical research facility in Northern Queensland. Specialising in Phase II and III Gastroenterology trials, Coral Sea Clinical Research Institute work alongside a team of leading, internationally recognised Gastroenterologists to deliver high quality clinical trials. At Coral Sea Clinical Research Institute, our core mission is to enable patients living in regional Queensland to have access to clinical trial therapies.

Cullens are patent and trademark attorneys, providing a range of commercially focused services to meet all intellectual property needs, for businesses operating in the physical marketplace or online.

Cyteph is a clinical-stage spin-out company from QIMR Berghofer Medical Research Institute raising capital to further develop an allogeneic Cytomegalovirus (CMV)-specific T cell therapy for glioblastoma (GBM) and CAR-T cell platform for solid tumours. The CAR-T platform leverages the unique properties of CMV specific T-cells to overcome the challenges with safety, efficacy and persistence that current CAR-T therapies have faced in clinical development.

Danbar Consulting works with Universities, Research Institutes, Government and the Private Sector to plan and deliver projects that create significant social, economic and opportunity value with a focus on Life Sciences, Health and Education sectors.

Dave Collison Cave provide patent, trademark, design and copyright, commercialisation, privacy and data protection and services in Australia, New Zealand, Singapore and the ASEAN region.

Eevi is a leading provider of care technology solutions, supporting senior living with a diverse product portfolio that offers peace of mind and independence to customers and their families, serving over 10,000 lives across Australia through research-led design and innovative cloud-based technology, including 24/7 emergency care support, driven by a commitment to enabling better living and making a positive impact on the lives of individuals and communities.

Fovero Therapeutics are developing fully human anti-Galectin-9 (GAL9) monoclonal antibodies (mAbs) with a novel immune-synapse stabilising mechanism. Our GAL9 mAbs increase antigen-specific CD8+ T-cell activation and dendritic cell function, while simultaneously reducing regulatory T-cell-mediated immune-suppression, to generate strong anti-tumour immunity in pre-clinical models of colorectal and breast cancer.

Graythan Regulatory Services’ purpose is to add value to their clients’ drug development programs by providing services in the fields of drug development, program management, regulatory affairs, pharmacovigilance, medical writing and gene therapy applications.

Griffith University is ranked amongst the top 3% of universities globally, and has over 50,000 students spread across 5 campuses. Griffith’s health and bioscience research institutes collaborate with industry and public health sectors to deliver global benefits through outcomes such as novel drug leads, vaccines for combating infectious diseases, and healthy living programs.

Health Translation Queensland provides a platform for greater integration and collaboration between clinicians, educators, researchers, academics, policy makers and health consumers. As an NHMRC accredited Advanced Health Research and Translation Centre, we work to mobilise research into clinical practice, and support health system and business transformation.

IP Group was set up with a mission to evolve great ideas, mainly from partner universities, into world-changing businesses. IP Group aims to create, build and support outstanding intellectual property-based companies. IP Group Australia has partnered with the region’s leading universities, superannuation funds, and corporates to provide us with an unrivalled platform of science, capital, and expertise from which to build world-class companies.

James & Wells experience ranges from managing large IP portfolios for international corporations, right through to protecting the ideas of start-ups, and everything in between.

KJR is a software quality engineering consultancy that provides intelligent, technology-based solutions. They have been in operation since 1997, initially focusing on addressing the Y2K issue and have since become a leader in software quality and assurance. They offer services in software QA, DevSecOps, and data quality & AI assurance. KJR has a team of over 100 specialists across Australia and multiple offices in major cities.

Kings Patent & Trade Marks Attorneys is an independent firm in Brisbane, Australia, owned solely by its attorneys, specialising in providing high-quality patents, trademarks, and designs services to creative individuals and businesses, with a strong focus and expertise in the life sciences field, offering responsive, detail-oriented, and strategic support for long-term success, with an experienced team covering diverse technologies including life sciences, the mechanical arts, and software, and providing protection directly before Australian and New Zealand IP Offices or internationally through a reliable network of trusted advisors.

Life Sciences Queensland is an Australian peak industry group, working to assist the growth of individual firms and organisations, and build the profile, capacity and capability of the life sciences sector to ensure long-term economic, social and environmental benefits to Queensland. LSQ acts as the key point of contact for the life sciences industry.

MTPConnect is a not-for-profit organization in Australia that aims to accelerate the growth of the medical technology, biotechnology, and pharmaceutical (MTP) sector. It was established in December 2015 by the Australian Government as an independent organization. MTPConnect focuses on strengthening connections between research and industry to maximize opportunities for scientific and technological breakthroughs, as well as their translation and commercialization. Their key areas of focus include increasing collaboration and commercialization, improving management and workforce skills, enhancing access to global supply chains and international markets, and optimizing the regulatory environment.MTPConnect raises awareness, facilitates collaboration, aggregates knowledge, and jointly funds projects that address sector growth priorities and identified constraints and gaps. They have established key hubs in Adelaide, Perth, and Brisbane, along with their head office in Brighton, Victoria. The MTPConnect Board, led by Hon Jaala Pulford, consists of respected industry leaders.MTPConnect also runs various programs funded by the Medical Research Future Fund (MRFF) and other initiatives, supporting research and development in the MTP sector.

Michael Buck IP is an independent, boutique intellectual property firm, based in Brisbane Australia. We help creative, innovative and inventive people and businesses to protect, defend and commercialise their intellectual assets. Our clients range from local companies and individual inventors to start-ups, international corporations, universities and research organizations.

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.

PRAXIS Australia is leading national and international education and training provider of high-quality, relevant and accessible training to build the confidence and capability of those working in clinical trials, research and ethics. Their offers have been built upon Harvard Multi-Regional Trials Centre competencies and aligned to NHMRC competencies. These training offers are a benchmark for research and clinical trials professionals in Australia, New Zealand, Asia Pacific Region, Europe, and the United States.

Parasym is a neurotechnology company focused on providing cutting edge, wearable bioelectric treatment solutions that improve quality of life through targeted modulation of the autonomic nervous system. Parasym's tech has exciting application in cardiovascular disease with RCT results showing improvement in atrial fibrillation burden and QoL in heart failure patients.

Pfizer is a pharmaceutical company dedicated to making breakthroughs that improve patients' lives and promote global health. They have a long history of innovation and a commitment to social responsibility. Pfizer works with healthcare professionals to gather real-world information for developing treatments, and they strive to make medicines accessible to underserved communities. The company engages in political partnerships in a legal and transparent manner and supports initiatives aligned with their medical and scientific strategies. They invest in research and development, and their executives and scientists lead the way in driving innovation.

Pizzey's Patent & Trade Mark Attorney is a specialist intellectual property firm, focusing on patents, trademarks, and designs, with expertise in establishing, maintaining, and enforcing intellectual property rights in Australia, New Zealand, and Singapore, known for its leadership in IP rights protection, driven by qualified attorneys dedicated to upholding the highest standards, offering quality, personalized, and responsive service, and operating as members of the IPH Limited group.

Provectus Algae is an Australia-based biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.

QIMR Berghofer is one of Australia’s largest medical research institutes, renowned for its world-leading research in cancer, infection and inflammation, brain and mental health, and population health. QIMR Berghofer is home to almost 1,000 scientists, students and support staff in more than 60 state-of-the-art laboratories.

QUE Oncology is a clinical stage company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122, is focused on the treatment of hot flashes in breast cancer survivors undergoing endocrine therapy.

Queensland University of Technology (QUT) is a renowned Australian university that emphasizes a global perspective. With nearly 50,000 students, QUT offers real-world infrastructure, education, and graduate skills to empower the next generation of change-makers. Collaborating with various universities, institutions, and hospitals, QUT is dedicated to research excellence. Their research team is highly regarded for providing government, businesses, and organizations with top-notch research resources. QUT houses cutting-edge facilities and research groups focused on innovative research across various health disciplines. QUT is home to the Centre for Genomics and Personalised Health, contributing to advancements in personalized medicine.

Queensland is fast becoming Australia’s premier investment destination for biomedical and health industry projects. We have a dynamic and diverse economy supported by a pro-business government, sophisticated infrastructure and a skilled workforce.

QIC is a trusted investment manager and adviser providing risk adjusted returns for the clients we serve. As one of Australia’s leading institutional investment managers, we deliver alternative real asset solutions across infrastructure, real estate, private debt, private capital and natural capital in addition to a liquid market offering for our 125 Australian and global clients. We also act as the Queensland Government’s independent investment advisor, managing a fully-funded Defined Benefit scheme and the Queensland Future Fund both of which delivers on the State’s long-term investment objectives. We have US$65bn in assets under management (as at 31 March 2023) and are headquartered in Brisbane, Australia, with offices in Sydney, Melbourne, New York, San Francisco and London.

Sacco System embodies the fusion of international biotech expertise, catering to the food, nutraceutical, and pharmaceutical industries while supporting food culture and life, with its unique and collaborative network of Caglificio Clerici, Sacco, Centro Sperimentale del latte srl, and Kemikalia, offering a diverse range of innovative products such as starter cultures for food fermentation (especially dairy), nutritional supplements (probiotic cultures), and food enhancement instruments, preserving the distinct qualities and production capabilities of each entity.

Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.

We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.

Thermo Fisher Scientific is a company focused on enabling customers to make the world healthier, cleaner, and safer. They provide products and services in various areas, including genetic testing research, environmental goals, fertility restoration, and community support. The company emphasizes diversity and inclusion and strives to create an environment where differences are valued and everyone feels they belong. Thermo Fisher Scientific also highlights its corporate social responsibility and commitment to making a positive impact on society.

Thomson Geer is a large Australian corporate law firm, delivering services to a wide range of industry sectors and practice areas. Thomson Geer has offices in Sydney, Melbourne, Brisbane and Adelaide. By size, they are one of the 10 largest law firms in Australia.

Toowoomba and Surat Basin Enterprise (TSBE) is the go-to organisation linking business with opportunity to create sustainable growth and diversity for the region. TSBE is an independent, member-driven economic development organisation actively linking our business community to opportunities across the Toowoomba, Western Downs, Maranoa and surrounding areas.

The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.

The University of Southern Queensland (USQ) is a young, dynamic university. USQ has campuses in the regional centres of Toowoomba, Springfield and Ipswich. USQ is internationally recognised for delivering practical, world-class research that delivers high-impact solutions.

USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.

Uniseed is Australia’s longest running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and a leading Australian Superannuation Fund, UniSuper. These research organisations collectively spend $4 billion on research annually, making up over 40% of the total research spend in all research organisations in Australia.

The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.

Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.

WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020.